FULGENT GENETICS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
FULGENT GENETICS, INC. (FLGT) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $995.99 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-07-30
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $995.99M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1.04B.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1.11B.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1.12B.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $995.99M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $1.04B 10-Q · filed 2026-07-30 |
| 2025-12-31 | $1.11B 10-Q · filed 2026-07-30 |
| 2025-09-30 | $1.12B 10-Q · filed 2025-11-07 |
| 2025-06-30 | $1.11B 10-Q · filed 2026-07-30 |
| 2025-03-31 | $1.12B 10-Q · filed 2026-07-30 |
| 2024-12-31 | $1.13B 10-Q · filed 2026-07-30 |
| 2024-09-30 | $1.13B 10-Q · filed 2025-11-07 |
| 2024-06-30 | $1.13B 10-Q · filed 2025-11-07 |
| 2024-03-31 | $1.13B 10-Q · filed 2025-11-07 |
| 2023-12-31 | $1.13B 10-K · filed 2026-02-27 |
| 2023-09-30 | $1.26B 10-Q · filed 2024-11-08 |
| 2023-06-30 | $1.26B 10-Q · filed 2024-11-08 |
| 2023-03-31 | $1.27B 10-Q · filed 2024-11-08 |
| 2022-12-31 | $1.27B 10-K · filed 2026-02-27 |
| 2022-09-30 | $1.28B 10-Q · filed 2023-11-03 |
| 2022-06-30 | $1.31B 10-Q · filed 2023-11-03 |
| 2022-03-31 | $1.31B 10-Q · filed 2023-11-03 |
| 2021-12-31 | $1.17B 10-K · filed 2025-02-28 |
| 2021-09-30 | $1.04B 10-Q · filed 2022-11-07 |
| 2021-06-30 | $920.73M 10-Q · filed 2022-11-07 |
| 2021-03-31 | $801.57M 10-Q · filed 2022-11-07 |
| 2020-12-31 | $569.39M 10-K · filed 2024-02-28 |
| 2020-09-30 | $186.96M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $87.04M 10-Q · filed 2021-11-09 |
| 2020-03-31 | $81.37M 10-Q · filed 2021-11-09 |
| 2019-12-31 | $82.78M 10-K · filed 2023-02-28 |
| 2018-12-31 | $51.15M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |